OptimizeRx Reports First Quarter 2019 Results; Total Revenue Up 27% to $5.2 Million, Driving Non-GAAP Net Income up 130% to $833,000 or $0.06 per Diluted Share

Read More

EVERSANA and OptimizeRx Partner to Deliver High Tech and High Touch Pharmaceutical Services

Read More

OptimizeRx Strengthens Executive Leadership with Appointment of Chief Commercial Officer

Read More

OptimizeRx Corporation - Delivering Results in Digital Health

Read More

OptimizeRx to Present at Investor Conferences in May

Read More

Optimizing Patient Outcomes

Read More

Four Key Questions About Point of Care in 2019

Read More

Doctors, patients and prescription drug prices insights from OptimizeRx physician survey on drug price transparency and patient cost challenges

Read More

OptimizeRx Expands Investment in Hospitals and Health Systems with Latest Tech and Personnel Adds

Read More

The Prescription Coupon Distribution Problem – Industry Perspectives from HIMSS 2019

Read More